September 22 2025

Chrysotile asbestos – the deadly consequences of a retreat from national bans

The news out of the U.S in June that the Environmental and Protection Agency (U.S EPA) was reconsidering the country’s ban on chrysotile asbestos sent shockwaves through the global clinical and research community.

At ADDRI, we know what science and decades of evidence tells us about asbestos: there’s no safe use. Read our article published in the September edition of The Lancet Respiratory Medicine Journal which underscores why our work matters so much — advocating for evidence-based policy, driving research and ensuring patient protection can’t be sidelined.

We need to stay vigilant – the health and safety of communities must always come first. Global bans are the only way to make sure this happens.

You can read the article here or download a PDF of the article here.

Sign up to our newsletter

Sign up
Skip to content